Long-term outcome of neoadjuvant tislelizumab plus chemotherapy in locally advanced esophageal squamous cell carcinoma

Abstract Background Current understanding of neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma (ESCC) lacks high-level evidence. This study provides additional efficacy data for this treatment regimen. Methods Clinical trials investigating neoadjuvant tislelizuma...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Hao Yin, Xinyu Yang, Yujie Chen, Hongtao Duan, Jie Wang, Xuqiang Liao, Guangyu Yao, Fei Liang, Hong Fan, Gao Li, Yihua Sun, Xiaolong Yan, Peiyuan Wang, Lijie Tan
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Springer 2025-12-01
Serie:	Cancer Immunology, Immunotherapy
Soggetti:	Neoadjuvant Tislelizumab plus chemotherapy Advanced esophageal squamous cell carcinoma
Accesso online:	https://doi.org/10.1007/s00262-025-04240-8
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!